Company acquires Makara Health, who will work alongside Precision’s branded medical and scientific agency.
Precision Value & Health, a New York-based company that provides commercialization services that range from market intelligence platforms to value and access solutions, has acquired Makara Health, a healthcare communications agency located in the UK. The move—says Precision—will expand its European footprint and reinforce the company’s market growth position with its principal capabilities in the region.
The acquisition of Makara boosts Precision Value & Health’s ability to offer pharma clients in Europe culturally aligned programs, along with support to achieve their business objectives. The company has specializations in learning and development, medical and patient education, PR, and brand promotion. It will be working closely with PRECISIONscientia, an agency that delivers medical and scientific communications.
“Broadening the reach of our services in Europe is one of Precision Value & Health's focused strategies in order to extend our offering to more organizations and healthcare clinicians around the world,” comments Doug Fulling, president of Precision Value & Health.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.